Fujun Yu

Wenzhou, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 74 publications

Correction to: Resveratrol ameliorates liver fibrosis by inhibiting ATF4 to regulate glutamine metabolism in hepatic stellate cells.

Correction to: Resveratrol ameliorates liver fibrosis by inhibiting ATF4 to regulate glutamine metabolism in hepatic stellate cells.

Journal: Archives of pharmacal research
Published: January 19, 2026

Acacetin ameliorates MASLD by inhibiting the Notch1 pathway in hepatocytes and reprogramming macrophage polarization via Keap1-Nrf2-mediated restraint of ferroptosis.

Acacetin ameliorates MASLD by inhibiting the Notch1 pathway in hepatocytes and reprogramming macrophage polarization via Keap1-Nrf2-mediated restraint of ferroptosis.

Journal: Metabolism: clinical and experimental
Published: October 22, 2025

Psoas muscle CT radiomics-based machine learning models to predict response to infliximab in patients with Crohn's disease.

Psoas muscle CT radiomics-based machine learning models to predict response to infliximab in patients with Crohn's disease.

Journal: Annals of medicine
Published: July 05, 2025

Ginsenoside RK1 Promotes Hepatic Stellate Cell Glycolysis-Mediated Ferroptosis by Activating the HK2/ACSL4/LPCAT3/ALOX5 Signaling Pathway.

Ginsenoside RK1 Promotes Hepatic Stellate Cell Glycolysis-Mediated Ferroptosis by Activating the HK2/ACSL4/LPCAT3/ALOX5 Signaling Pathway.

Journal: Journal of agricultural and food chemistry
Published: June 26, 2025

Interactions between hepatic stellate cells and immune cells: Implications for liver fibrosis.

Interactions between hepatic stellate cells and immune cells: Implications for liver fibrosis.

Journal: Biochimica et biophysica acta. Molecular basis of disease
Published: June 01, 2025

Title: Resveratrol ameliorates liver fibrosis by inhibiting ATF4 to regulate glutamine metabolism in hepatic stellate cells.

Title: Resveratrol ameliorates liver fibrosis by inhibiting ATF4 to regulate glutamine metabolism in hepatic stellate cells.

Journal: Archives of pharmacal research
Published: May 12, 2025

Ablation for hepatocellular carcinoma in hepatitis B-related recompensated vs. compensated cirrhosis.

Ablation for hepatocellular carcinoma in hepatitis B-related recompensated vs. compensated cirrhosis.

Journal: European radiology
Published: May 06, 2025

Ghrelin attenuates metabolic dysfunction-associated steatotic liver disease by activating glutamine metabolism via inhibition of the IRE1α-XBP-1 pathway.

Ghrelin attenuates metabolic dysfunction-associated steatotic liver disease by activating glutamine metabolism via inhibition of the IRE1α-XBP-1 pathway.

Journal: Biochemical pharmacology
Published: March 27, 2025

Melatonin reverses lenvatinib resistance in HCC by regulating the ATF4-NRF1 pathway mediated by ceramide synthase 6.

Melatonin reverses lenvatinib resistance in HCC by regulating the ATF4-NRF1 pathway mediated by ceramide synthase 6.

Journal: Cellular signalling
Published: January 24, 2025

Predictive value of three nutritional indexes for disease activity in patients with inflammatory bowel disease.

Predictive value of three nutritional indexes for disease activity in patients with inflammatory bowel disease.

Journal: Annals of medicine
Published: December 20, 2024

L3-SMI as a predictor of overall survival in oesophageal cancer patients receiving PD-1 inhibitors combined with chemotherapy.

L3-SMI as a predictor of overall survival in oesophageal cancer patients receiving PD-1 inhibitors combined with chemotherapy.

Journal: Annals of medicine
Published: December 12, 2024

Machine learning assisted radiomics in predicting postoperative occurrence of deep venous thrombosis in patients with gastric cancer.

Machine learning assisted radiomics in predicting postoperative occurrence of deep venous thrombosis in patients with gastric cancer.

Journal: BMC cancer
Published: November 10, 2024
Showing 1-12 of 74

Last Updated: 09/26/2026